Please login to the form below

Not currently logged in
Email:
Password:

European Society of Cardiology

This page shows the latest European Society of Cardiology news and features for those working in and with pharma, biotech and healthcare.

FDA approves first Apple Watch medical device accessory

FDA approves first Apple Watch medical device accessory

In September, AliveCor presented data from studies at the European Society of Cardiology Congress In Barcelona showing that patients using Kardia Mobile were four times more likely to have their AF ... detected, and that the diagnostic accuracy of the

Latest news

  • Merck & Co's anacetrapib data fails to generate much excitement Merck & Co's anacetrapib data fails to generate much excitement

    Merck &Co's anacetrapib data fails to generate much excitement. Treatment proves unable to reduce a composite outcome of major atherosclerotic events. ... This week, Merck presented the results from the 30, 000-patient trial in full at the European

  • Novartis and Bayer among backers for European big data project Novartis and Bayer among backers for European big data project

    Its overarching aim is to improve patient outcomes and reduce the burden on society of atrial fibrillation (AF), heart failure (HF) and acute coronary syndrome (ACS). ... As part of that the partners, which also include University Medical Center Utrecht,

  • Merck & Co's anacetrapib rescued by positive phase III trial Merck & Co's anacetrapib rescued by positive phase III trial

    A final decision on commercialisation will likely depend on the magnitude of the benefit on MACE in REVEAL. ... For now, that data is under wraps but cardiologists will get a chance to pore over the numbers when REVEAL is presented at the European

  • CV data sets up Novartis' Ilaris for blockbuster sales CV data sets up Novartis' Ilaris for blockbuster sales

    There is still some way to go before approval - including presenting the data to cardiologists (most likely at the European Society of Cardiology Congress in August) - and discussing with regulators what ... Even if approved, Novartis' experience with

  • EU forms mHealth app working group EU forms mHealth app working group

    The European Commission is working towards improving the safety and transparency of health information collected by mobile apps. ... The 20 members of its mHealth working groups represent civil society, research and industry organisations and include the

More from news
Approximately 2 fully matching, plus 37 partially matching documents found.

Latest Intelligence

  • Is it possible to change behaviour virtually? Is it possible to change behaviour virtually?

    One of my colleagues, Emma, has also incorporated virtual technology into a medical education programme. ... What value did the virtual mannequin add? It was the first time ever a virtual mannequin had been used at the European Society of Cardiology (ESC)

  • Helping European cardiologists keep up to date Helping European cardiologists keep up to date

    Helping European cardiologists keep up to date. Research reveals significant local differences in how the future of CME is seen. ... But when asked about their propensity to take part in programmes in relation to: (1) the sponsoring organisation

  • Change drivers: multi-stakeholder education and collaboration Change drivers: multi-stakeholder education and collaboration

    Professor John Camm, Chair of the European Society of Cardiology Committee for Guidelines on the Management of Atrial Fibrillation told me recently: “ Well-meaning rewording of key messages to 'suit' different ... It resulted in improved cholesterol

More from intelligence
Approximately 0 fully matching, plus 3 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Life Healthcare Communications

Life is a creative communications agency offering multi-channel solutions for the healthcare industry. We use a storytelling approach to turn...

Latest intelligence

Why heading online for scientific meetings can yield greater HCP engagement
Modern conferencing methods, with enhanced digital information transfers, offer unique opportunities for greater HCP engagement....
The threat of antimicrobial resistance
Why this issue is such a fundamental challenge...
Meet the CEO behind ReNeuron’s cutting-edge stem cell therapies
Blue Latitude Health speaks to Olav Hellebo, CEO of ReNeuron, to find out about the biotech’s latest innovation in stem cell therapy and to learn his perspective on navigating the...

Infographics